10-Q: Centrus Energy Q1 2026: Revenue Dip, HALEU Growth

Sentiment:

Quarterly Report


Centrus Energy Corp. reported a decrease in Q1 2026 revenue driven by lower SWU sales, while Technical Solutions segment revenue increased significantly due to HALEU operations.

Delay expectedPhase 2 of the HALEU Operation Contract was extended through June 2025 due to delays in obtaining 5B Cylinders from the DOE.The fee for the extended Phase 2 period of performance was not definitized and is subject to negotiation.The DOE's fiscal year 2027 budget proposal does not include funding for the operation of the HALEU cascade, creating uncertainty for future operations.
Capital raiseThe company issued $402.5 million in 2.25% Convertible Notes due 2030 and $805.0 million in 0% Convertible Notes due 2032. Proceeds are for general working capital and corporate purposes.In Q1 2025, the company sold 258,197 shares of Class A Common Stock under ATM offerings, raising $25.4 million in net proceeds.The company has an effective shelf registration statement allowing for the offer and sale of up to $1.0 billion in securities.The company plans to invest over $560 million over several years to transition its Oak Ridge centrifuge manufacturing plant to high-rate manufacturing.The company is seeking substantial public and private investment for the expansion of its LEU production capacity.
Worse than expectedNet income decreased by 63% to $10.0 million compared to $27.2 million in the prior year's quarter.Operating income saw a significant decline from $20.5 million to $0.8 million.Advanced technology costs increased by 530%, heavily impacting profitability.LEU segment revenue decreased by 13% due to lower sales volumes.

Summary

  • Centrus Energy Corp. reported total revenue of $76.7 million for the first quarter of 2026, a slight increase from $73.1 million in the same period of 2025.
  • Revenue from the LEU segment decreased by 13% to $44.6 million, primarily due to a 47% decrease in the volume of Separative Work Units (SWU) sold, although the average price increased by 52%.
  • The Technical Solutions segment saw a substantial revenue increase of 47% to $32.1 million, largely driven by higher revenue from the HALEU Operation Contract.
  • Gross profit decreased by 4% to $31.5 million, with the LEU segment's gross profit down 11% and the Technical Solutions segment's gross profit up 112%.
  • Advanced technology costs significantly increased by 530% to $18.9 million, impacting operating income, which fell from $20.5 million to $0.8 million.
  • Net income for the quarter was $10.0 million, a decrease from $27.2 million in the prior year's quarter.
  • The company's cash and cash equivalents stood at $1.9 billion as of March 31, 2026, indicating strong liquidity.
  • Centrus is investing significantly in expanding its uranium enrichment capacity in Oak Ridge, Tennessee, and Piketon, Ohio, with plans for high-rate manufacturing and large-scale LEU and HALEU production.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed sentiment, with significant strategic progress in HALEU and capacity expansion offset by a decline in current profitability and ongoing geopolitical/regulatory risks.

Positives

  • Significant revenue growth in the Technical Solutions segment (47% increase) driven by HALEU operations.
  • Increase in the average price of SWU sold by 52%, partially offsetting lower sales volume.
  • Strong liquidity position with $1.9 billion in cash and cash equivalents as of March 31, 2026.
  • Continued progress and investment in expanding domestic uranium enrichment capacity for both LEU and HALEU.
  • Awarded a $900 million task order by the DOE for HALEU production expansion, with options for an additional $170 million.
  • Secured a $62.4 million clean energy tax credit allocation for re-equipping its Oak Ridge manufacturing facility.
  • Exploration of a joint venture with Oklo Inc. for HALEU deconversion services, aiming to create a domestic nuclear fuel ecosystem.

Negatives

  • Decrease in LEU segment revenue by 13% due to a 47% drop in SWU sales volume.
  • Significant increase in advanced technology costs (530%) impacting profitability.
  • Sharp decline in operating income from $20.5 million to $0.8 million.
  • Substantial decrease in net income by 63% to $10.0 million.
  • The Phase 2 of the HALEU Operation Contract had undefinitized fees subject to negotiation.
  • The DOE's fiscal year 2027 budget proposal does not include funding for the operation of the HALEU cascade, posing a risk if additional funding is not secured.
  • Continued reliance on Russian supply (TENEX) for LEU, with ongoing risks related to sanctions, import bans, and export licenses.

Risks

  • Geopolitical conflicts, including the war in Ukraine, and resulting government measures (sanctions, bans, tariffs) could impact the ability to obtain, deliver, transport, sell, or collect payment for LEU or its components.
  • Reliance on third-party suppliers for essential products and services.
  • Restrictions on imports and exports, including those imposed under the Russian Suspension Agreement (RSA) and the Import Ban Act.
  • Government contracts are subject to changes in U.S. government appropriated funding levels and potential government shutdowns.
  • Uncertainty regarding the timing, nature, and amount of future task orders under HALEU and LEU production contracts.
  • The need to obtain new contracts or funding to continue operations.
  • Uncertainty about when and at what level government or commercial demand for HALEU or LEU will materialize.
  • Potential for supply/demand imbalances in the LEU market.
  • Significant competition from major LEU producers, including foreign competitors.
  • Limitations on the ability to compete in foreign markets.
  • Pricing trends and demand in the uranium and enrichment markets, especially given potential limited supply and dependence on others for LEU deliveries.
  • Challenges in successfully implementing planned expansion projects.
  • Risks associated with integrating artificial intelligence technologies into operations.
  • Natural disasters, pandemics, and other health crises.
  • Revenue is largely dependent on a few key customers and the sales backlog.
  • Long-term liabilities, including postretirement obligations and convertible notes.
  • Failures or security breaches, including cybersecurity, of information technology systems.
  • Impact of, or changes to, government regulation and policies or interpretation of laws.
  • The risk that the DOE may not commit to additional costs above existing funding for the HALEU Operation Contract, potentially leading to material additional costs or losses.
  • The Import Ban Act and the Russian Decree pose significant risks to the business due to reliance on the TENEX Supply Contract.
  • Potential imposition of new or increased tariffs on processed critical minerals, including uranium.
  • Challenges in processing payments to Russia and obtaining services like transportation due to sanctions.
  • The potential for the USTR to impose significant fees on Chinese-built vessels used for shipping Russian LEU.
  • The possibility of TENEX refusing or suspending deliveries under the TENEX Supply Contract.
  • The uncertainty of obtaining future waivers from the DOE for Russian LEU imports.
  • The uncertainty of TENEX obtaining timely export licenses from Russian authorities.
  • The risk that the DOE's fiscal year 2027 budget proposal does not include funding for the HALEU cascade operation.
  • The potential for AI technologies to introduce new risks, including operational disruptions, data issues, security breaches, and regulatory uncertainty.
  • The need to secure substantial public and private investment for the expansion of LEU production capacity.

Future Outlook

Centrus anticipates having adequate liquidity for at least the next 12 months, supported by its strong cash position. The company is focused on expanding its domestic uranium enrichment capacity for both LEU and HALEU, leveraging government contracts and private investment. The outlook is influenced by market conditions, international trade policies, and the successful execution of expansion projects. The company is also exploring strategic partnerships and potential transactions to grow its business.

Management Comments

  • The Company does not have a contractual obligation to perform work in excess of the funding provided by the DOE. If the DOE does not commit to additional costs above the existing funding, the Company may incur material additional costs or losses in future periods that could have an adverse impact on its financial condition and liquidity.
  • Centrus plans to leverage its multi-billion-dollar uranium enrichment expansion to meet its growing backlog of $2.4 billion in contingent LEU sales to U.S. and international customer contracts, along with commercial-scale HALEU production.
  • Centrus believes developing enrichment and deconversion services at its Piketon location will raise efficiency, expand domestic capacity, and help solve what is widely viewed as a potential nuclear fuel bottleneck to the pace of large-scale deployment of advanced nuclear power technology.
  • The Company believes its investments in advanced enrichment technology and its progress in demonstrating HALEU production will position the Company to meet the needs of government and commercial customers in the future as they deploy advanced reactors and next generation fuels and also offers potential cost synergies for a return to LEU production.

Industry Context

StockSavvy.ai notes that Centrus Energy's Q1 2026 results reflect the ongoing global energy transition and the strategic importance of domestic nuclear fuel production. The company's focus on HALEU aligns with the U.S. government's initiatives to secure advanced nuclear fuel supply chains and reduce reliance on foreign sources, particularly Russia. The increased SWU spot prices, driven by geopolitical uncertainty, highlight the volatility and strategic value of uranium enrichment services.

Comparison to Industry Standards

  • The SWU spot price reached $200 per SWU as of March 31, 2026, a significant increase from its low of $34 per SWU in August 2018, indicating a strong recovery and heightened market demand for enrichment services.
  • Global nuclear energy generation is projected to grow substantially, with the IEA forecasting a 38% increase by 2035 and 62% by 2040 under the Stated Policies scenario.
  • As of March 2026, 78 reactors are under construction worldwide, with approximately half in China, indicating significant global activity in nuclear power deployment.
  • The United States, with 94 operating reactors, remains the largest market for nuclear fuel, but faces competition from subsidized renewables and low-cost natural gas.

Legal Proceedings

  • DOE assertion of approximately $9.6 million in liability for Joppa Power Plant D&D costs against Enrichment Corp.
  • Class action complaint filed by McGlone Plaintiffs alleging off-site contamination from activities at the Portsmouth GDP site.
  • Complaint filed by Brad Allen Lykins estate alleging release of radiation causing death.
  • Complaint filed by Christian Rose alleging release of radiation causing cancer.
  • Complaint filed by Joshua Shaw alleging release of radiation causing Acute Myeloid Leukemia (AML).
  • Complaint filed by Julia Dunham alleging release of radiation causing death.

Stakeholder Impact

  • Shareholders: Potential for future growth driven by HALEU expansion and strategic investments, but current profitability decline and geopolitical risks may impact share price.
  • Employees: Continued investment in advanced technology and expansion projects may lead to job creation and skill development.
  • Customers: Continued supply of LEU and potential for increased domestic HALEU production, but reliance on Russian supply and potential disruptions pose risks.
  • Suppliers: Increased demand for materials and services related to expansion projects.
  • Creditors: Strong liquidity position and convertible note issuances impact debt structure and financial obligations.

Next Steps

  • Negotiate definitive agreement for the $900 million HALEU Production Contract task order with the DOE.
  • Continue to pursue waivers from the DOE for Russian LEU imports.
  • Continue to monitor and address potential impacts of sanctions and trade restrictions on TENEX supply.
  • Complete construction activities for the training, operations, and maintenance facility in Piketon, Ohio.
  • Transition the Oak Ridge centrifuge manufacturing plant to high-rate manufacturing.
  • Explore opportunities for potential coordination of regulatory and R&D activities with Oklo Inc. for HALEU deconversion services.
  • Monetize clean energy tax credits received through transfer to unrelated taxpayers for cash.
  • Continue to evaluate strategic transactions, which may include acquisitions, dispositions, joint ventures, or changes to capital structure.

Key Dates

DateDescription
2019-01-01HALEU Demonstration Contract signed with DOE.
2022-11-01DOE awarded HALEU Operation Contract.
2023-11-01Company announced first contractual delivery of HALEU to DOE, completing Phase 1 of HALEU Operation Contract.
2024-02-24Notice of redemption issued for 8.25% Notes.
2024-05-13U.S. enacted the Import Ban Act, banning imports of LEU from Russia starting August 11, 2024.
2024-10-04DOE awarded HALEU Deconversion Contract to ACO.
2024-10-16DOE awarded HALEU Production Contract to ACO.
2024-11-06Company filed an automatic shelf registration statement on Form S-3.
2024-11-07Company issued 2.25% Convertible Notes.
2024-11-20Company announced resumption of centrifuge manufacturing activities and expansion of capacity in Oak Ridge, Tennessee.
2024-12-10DOE awarded LEU Production Contract to ACO.
2024-12-01Centrifuge manufacturing began in Oak Ridge, Tennessee.
2025-01-05DOE announced ACO was awarded a $900.0 million task order to expand its uranium enrichment facility for HALEU production.
2025-01-10Company informed that IRS granted its request for a $62.4 million credit allocation for the Oak Ridge facility.
2025-01-23Company announced plans to invest over $560 million to transition Oak Ridge plant to high-rate manufacturing.
2025-02-09ACO entered into an EPC contract with Fluor Federal Services, Inc. for commercial expansion and deployment of LEU and HALEU production capability.
2025-03-26Company redeemed all outstanding 8.25% Notes.
2025-04-15President signed an Executive Order initiating a DOC investigation into imports of processed critical minerals.
2025-05-09Prospectus supplement filed for the 2023 shelf registration statement.
2025-06-17DOE issued an amendment to the HALEU Operation Contract, splitting the first three-year option period and exercising Option 1a.
2025-06-30Phase 2 of the HALEU Operation Contract was extended through this date.
2025-07-102023 shelf registration statement became effective.
2025-09-25Centrus announced plans for a major expansion of its uranium enrichment capacity in Piketon, Ohio.
2025-10-02Russian Federal Decree No. 1516 enacted, extending Russian Decree No. 1544 through December 31, 2027.
2025-11-06Company filed an automatic shelf registration statement on Form S-3.
2025-12-01Company initiated design work on a training, operations and maintenance facility in Piketon, Ohio.
2025-12-01Company began domestic centrifuge manufacturing to support commercial LEU enrichment activities at its Piketon, Ohio, facility.
2026-01-05DOE announced ACO was awarded a $900.0 million task order to expand its uranium enrichment facility for HALEU production.
2026-01-10Company was informed that the IRS granted its request for a $62.4 million credit allocation for the Oak Ridge facility.
2026-01-20Executive Order 14154, Unleashing American Energy, was signed.
2026-01-23Company announced plans to invest over $560 million to transition Oak Ridge plant to high-rate manufacturing.
2026-02-09ACO entered into an EPC contract with Fluor Federal Services, Inc. for commercial expansion and deployment of LEU and HALEU production capability.
2026-03-08Christian Rose complaint filed against Centrus and others.
2026-03-19Court granted McGlone Plaintiffs motion for leave to amend complaint.
2026-03-23Company, Enrichment Corp., and others filed motion to dismiss Dunham Complaint.
2026-03-31Court did not grant Centrus' motion to dismiss Shaw Complaint as time-barred.
2026-04-14Company, Enrichment Corp., and others filed answer to amended Shaw Complaint.
2026-04-17Office of the USTR released notice regarding investigation into China's dominance in maritime, logistics, and shipbuilding sectors.
2026-04-28Company, Enrichment Corp., and others filed answer to the fourth amended complaint in McGlone case.
2026-04-30No convertible notes were converted during the quarter.
2026-05-01Semi-annual interest payment due on 2.25% Convertible Notes.
2026-05-06Report filing date.
2026-06-30Option 1a of Phase 3 of the HALEU Operation Contract period of performance ends.
2026-12-31Russian Federal Decree No. 1544, as extended, expires.
2027-01-10Company has until this date to provide evidence that requirements of the 48C credit have been met.
2027-01-31Phase 2 of the HALEU Operation Contract period of performance was extended through this date.
2027-03-01Canadian permit for shipper to transport LEU from Russia to the U.S. expires.
2027-12-31Russian Federal Decree No. 1516, extending Russian Decree No. 1544, expires.
2028-01-01Company has two years from January 10, 2025, to notify DOE that qualified investment in eligible property is placed in service to receive the 48C credit allocation.
2028-12-31TENEX Supply Contract commitments may extend to this date.
2030-11-01Maturity date for 2.25% Convertible Notes.
2030-12-31Orano Supply Agreement for SWU runs through this date.
2032-08-15Maturity date for 0% Convertible Notes.
2040-01-01RSA extension allows for Centrus shipments to the U.S. through this date.

Recommendation

hold

Centrus Energy presents a complex investment profile. While the company is strategically positioned to benefit from the growing demand for domestic nuclear fuel, particularly HALEU, and is making significant investments in capacity expansion, the current financial results show a decline in profitability. The substantial increase in advanced technology costs, coupled with ongoing geopolitical risks related to Russian supply and regulatory uncertainties, warrants a cautious approach. The strong liquidity and DOE contract awards are positive, but the path to sustained profitability and growth is subject to numerous external factors and execution risks. Therefore, a 'hold' recommendation is appropriate, pending clearer signs of improved financial performance and reduced geopolitical headwinds.

Keywords

Centrus Energy, LEU, HALEU, Uranium Enrichment, Nuclear Fuel, SWU, DOE Contract, Technical Solutions, American Centrifuge Plant, Form 10-Q, SEC Filing, Q1 2026

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.